Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2017/10/010064
CTRI/2017/10/010064
Completed
未知

A randomized controlled clinical trial to study the effect of tranexaemic acid in head neck surgery - none

il0 sites92 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: C07- Malignant neoplasm of parotid glandHealth Condition 2: null- Patients suffering with different head and neck cancers and fit to undergo surgeryHealth Condition 3: C775- Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C07- Malignant neoplasm of parotid glandHealth Condition 2: null- Patients suffering with different head and neck cancers and fit to undergo surgeryHealth Condition 3: C775- Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes
Sponsor
il
Enrollment
92
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 25, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
il

Eligibility Criteria

Inclusion Criteria

  • •Adult patients (minimum of eighty patients) suffering with different head and neck tumor (benign or malignant with/without nodal metastasis) undergoing different head neck surgeries under general anaesthesia will be enrolled after obtaining informed consent. These patients will be enrolled in two groups with each group having control.
  • •Group 1: Patients undergoing total thyroidectomy, total parotidectomy, comprehensive or selective neck dissection with or without primary tumour excision
  • •Group 2: Patient undergoing thyroid lobectomy or hemithyroidectomy and superficial parotidectomy without neck dissection.

Exclusion Criteria

  • •1\. A history of preoperative chemotherapy or radiotherapy.
  • •2\. Patients with allergic to tranexaemic acid
  • •3\. Any coagulopathy/bleeding disorder/deep vein thrombosis/peripheral vascular diseases.
  • •4\. Patients on anticoagulant / antiplatelet/ antifibrinolytic drugs
  • •5\. Coronary artery disease, chronic renal insufficiency, hematuria, Uncontrolled hypertension
  • •6\. Patients opting not to participate in the trial i.e. who do not give consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Clinical trial to study the efficacy of Vidangadi Mandura in panduroga with special reference to iron deficiency anaemia between age 6 to 12 years.Health Condition 1: D509- Iron deficiency anemia, unspecified
CTRI/2024/08/072272Dr Shubhangi Rajendra Divekar
Not yet recruiting
Not Applicable
Effect Of Triphala Kwath Parisheka(Stye).Health Condition 1: H000- Hordeolum (externum) (internum) ofeyelid
CTRI/2024/08/072323Dr Shivani Virkar
Not yet recruiting
Phase 2
Effect of Devdaru Choorna in Prameha (Diabetes Mellitus Type 2)Health Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2024/08/072285Dr Samiksha Bhure
Not yet recruiting
Phase 2
A clinical trial to study the effect of Triphala churna with Madhu in Timir with special reference to Simple MyopiaHealth Condition 1: H521- Myopia
CTRI/2024/08/072268Dr Ashwini Raosaheb Borude
Not yet recruiting
Phase 2
To study the effect of Triphala Khadir kashaya in diaper rash
CTRI/2023/03/051097Dr Vikas Gautam Harkar